Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;31 Suppl 1(Suppl 1):32-34.

Top-ten papers in fungal infection (2015-2017)

P Puerta-Alcalde  1 , C Cardozo, A Soriano, C García-Vidal
Affiliations
Review

Top-ten papers in fungal infection (2015-2017)

P Puerta-Alcalde et al. Rev Esp Quimioter. 2018 Sep.

Abstract
in English, Spanish

We have clustered the published articles in fungal infection between 2016 and 2017 in four categories. First, the emergence of Candida auris as a nosocomial pathogen associated to high antifungal resistance and high mortality. Second, the growing importance of fungal infections associated to the use of biologic therapies. Third, the approval of isavuconazole for the treatment of filamentous fungi and dymorphic mycoses with positive results and less side effects. And finally, a mix of other important news regarding empiric therapy, fluconazole toxicity and difficult-to-treat fungal infections..

Hemos agrupado los artículos publicados sobre infección fúngica entre 2016 y 2017 en cuatro categorías. Primero, la emergencia de Candida auris como un patógeno nosocomial asociado a alta resistencia a antifúngicos y alta mortalidad. Segundo, la creciente importancia de las infecciones fúngicas asociadas al uso de terapias biológicas. Tercero, la aprobación de isavuconazol para el tratamiento de los hongos filamentosos y las micosis por hongos dimórficos con buenos resultados y menos efectos adversos. Y por último, una combinación de otras noticias importantes en cuanto a terapia empírica, toxicidad del fluconazol e infecciones fúngicas difíciles de tratar.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Molecular Mechanisms of Antifungal Resistance in Mucormycosis.
    Ganesan P, Ganapathy D, Sekaran S, Murthykumar K, Sundramoorthy AK, Pitchiah S, Shanmugam R. Ganesan P, et al. Biomed Res Int. 2022 Oct 13;2022:6722245. doi: 10.1155/2022/6722245. eCollection 2022. Biomed Res Int. 2022. PMID: 36277891 Free PMC article. Review.

References

    1. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. . Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus—United States, May 2013–August 2016. Am J Transplant. 2017;17(1):296–9. PMID: DOI: 10.1111/ajt.14121 - DOI - PubMed
    1. Ruiz Gaitán AC, Moret A, López Hontangas JL, Molina JM, Aleixandre López AI, Cabezas AH, et al. . Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. Rev Iberoam Micol. 2017;34(1):23–7. PMID: DOI: 10.1016/j.riam.2016.11.002 - DOI - PubMed
    1. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. . Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–40. PMID: PMCID: DOI: 10.1093/cid/ciw691 - DOI - PMC - PubMed
    1. Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, et al. . Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med [Internet]. 2016;375(4):345–56. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1512711 - DOI - PubMed
    1. Topp MS, Gökbuget N, Stein AS, Zugmaier G, O’Brien S, Bargou RC, et al. . Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study. Lancet Oncol. 2015;16(1):57–66. PMID: DOI: 10.1016/S1470-2045(14)71170-2 - DOI - PubMed

Substances